A Phase II Study of Bevacizumab, Irinotecan and Capecitabine in Patients With Previously Untreated Metastatic Colorectal Cancer

NCT00483834 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

50

Enrollment

OTHER

Sponsor class

Conditions

Colorectal Cancer

Interventions

DRUG: Bevacizumab
DRUG: Irinotecan
DRUG: Capecitabine

Sponsor

University Health Network, Toronto

Collaborators

[object Object]